You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
Helping you help your heart failure patients feel better with our advanced therapies, monitoring solutions, and management services.
One in six people will develop heart failure.1,2 More than 670,000 new cases are diagnosed annually in the United States3 — 26 million patients worldwide.3 Heart failure is the most common cause of hospitalizations due to cardiovascular disease in patients over 654. These patients also face many personal challenges:
Cardiac Resynchronization Therapy (CRT) is a beneficial way to manage this disease. CRT is proven to6-14:
Our advanced therapies, monitoring solutions, and management services are designed to help you help your heart failure patients feel better — while improving the efficiency and effectiveness of heart failure care.
Ventricular Assist Device (VAD) is an effective means of managing advanced heart failure. As this therapy grows, we’re committed to partnering with you to advance the mechanical support field toward meeting these mutual goals:
Lloyd-Jones DM, et al. Circulation. 2002;106:3068-3072.
Wolinsky FD, et al. Med Care. 1997;35:1031-1043.
Ambrosy AP, et al. J Am Coll Cardiol. 2014;63:1123-1133.
Cowie MR, et al. Eur Heart J. 1997;18:208-225.
Mozaffarian D, et al. Circulation. 2016;133:e38-360.
Gold MR, et al. Reduced 30-Day Hospital Readmissions in Systolic Heart Failure Patients with Cardiac Resynchronization Therapy: Evidence from 5 Randomized Controlled Trials. Poster session – November 16, 2014 at AHA 2014.
Cleland JG, et al. N Engl J Med. 2005;352:1539-1549.
Cleland JG, et al. Eur Heart J. 2006;27:1928-1932.
Bristow MR, et al. N Engl J Med. 2004;350:2140-2150.
Abraham WT, et al. N Engl J Med. 2002;346:1845-1853.
Young JB, et al. JAMA. 2003;289:2685-2694.
Linde C, et al. J Am Coll. Cardiol. 2008;52:1834-1843.
Tang AS, et al. N Engl J Med. 2010;363:2385-2395.
Moss AJ, et al. N Engl J Med. 2009;361:1329-1338.